Cambridge Investment Research Advisors, Inc. - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 77 filers reported holding UTAH MED PRODS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q2 2019$227,000
-27.5%
2,373
-33.1%
0.00%
-33.3%
Q1 2019$313,000
+5.4%
3,546
-0.9%
0.00%0.0%
Q4 2018$297,000
-11.1%
3,577
+0.9%
0.00%0.0%
Q3 2018$334,000
-14.6%
3,5460.0%0.00%
-25.0%
Q2 2018$391,000
+11.4%
3,5460.0%0.00%0.0%
Q1 2018$351,000
+21.5%
3,5460.0%0.00%
+33.3%
Q4 2017$289,0003,5460.00%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2017
NameSharesValueWeighting ↓
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 165,563$9,464,0002.95%
Bares Capital Management 398,937$22,803,0001.97%
Ativo Capital Management LLC 7,072$404,0000.18%
Penobscot Investment Management Company, Inc. 7,400$423,0000.15%
Wallace Capital Management Inc. 10,001$572,0000.13%
Ancora Advisors LLC 11,389$651,0000.10%
Hillsdale Investment Management Inc. 4,400$252,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,300$2,075,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 16,380$936,0000.03%
Teton Advisors, Inc. 5,174$296,0000.02%
View complete list of UTAH MED PRODS INC shareholders